Braden Michael Leonard, 10% Owner at Adverum Biotechnologies, Inc. (ADVM), bought 673,512 shares at $4.01 ($2.9M) on 2025-02-26, disclosed to the SEC on 2025-02-28.
Open-market purchase of $2.9M ADVM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.01 | 164,886 | $661K | 23.0% |
| 2 | $4.01 | 164,886 | $661K | 23.0% |
| 3 | $4.46 | 86,802 | $387K | 13.4% |
| 4 | $4.46 | 86,802 | $387K | 13.4% |
| 5 | $4.60 | 85,068 | $391K | 13.6% |
| 6 | $4.60 | 85,068 |
| $391K |
| 13.6% |
| Total | $4.28 avg | 673,512 | $2.9M | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |